In particular, we addressed how CTLA-4Ig might impact peripheral blood-derived CD4pos cell subsets (Tregs and Th17), in combination with the modulation of IL6, IL-10, and TGFβ in naïve to bDMARDs RA. The gene discussed is IL6; the disease is rheumatoid arthritis.